Evidence map›Paper›PMID 37060186›Full record

ReviewCell proliferation2023

Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer.

Ting Wang, Zeng Ye, Zheng Li, De-Sheng Jing, Gui-Xiong Fan, Meng-Qi Liu, Qi-Feng Zhuo, Shun-Rong Ji, Xian-Jun Yu, Xiao-Wu Xu and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Cell proliferation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed
24.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 157 citations in OpenAlex.

  1. Review
  2. Review
  3. Research progress of lactylation modification in tumors (Review).Experimental and therapeutic medicine · 2026
    Review
  4. Tuning epigenetics to enhance cancer virotherapy.Acta pharmaceutica Sinica. B · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ting WangDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0002-8831-6215
Zeng YeDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Zheng LiDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0003-1953-1306
De-Sheng JingDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Gui-Xiong FanDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Meng-Qi LiuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Qi-Feng ZhuoDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Shun-Rong JiDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Xian-Jun YuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0002-6697-7143
Xiao-Wu XuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0001-5792-9839
Yi QinDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0001-9804-202X
Shanghai Medical College of Fudan University · CN

Funding

Clinical Research Plan of Shanghai Hospital Development Center SHDC2020CR1006ANational Natural Science Foundation of China 81972250National Natural Science Foundation of China 82141129National Natural Science Foundation of China 82172577National Natural Science Foundation of China 82172948National Natural Science Foundation of China 82173281National Natural Science Foundation of China U21A20374Science and Technology Commission of Shanghai Municipality 20ZR1471100Scientific Innovation Project of Shanghai Education Committee 2019-01-07-00-07-E00057Shanghai Municipal Science and Technology Major Project 21JC1401500Xuhui District Artificial Intelligence Medical Hospital Cooperation Project 2021-011
6 · The paper itself

Abstract

Lactate is not only an endpoint of glycolysis but is gradually being discovered to play the role of a universal metabolic fuel for energy via the 'lactate shuttle' moving between cells and transmitting signals. The glycolytic-dependent metabolism found in tumours and fast-growing cells has made lactate a pivotal player in energy metabolism reprogramming, which enables cells to obtain abundant energy in a short time. Moreover, lactate can provide favourable conditions for tumorigenesis by shaping the acidic tumour microenvironment, recruiting immune cells, etc. and the recently discovered lactate-induced lactylation moves even further on pro-tumorigenesis mechanisms of lactate production, circulation and utilization. As with other epigenetic modifications, lactylation can modify histone proteins to alter the spatial configuration of chromatin, affect DNA accessibility and regulate the expression of corresponding genes. What's more, the degree of lactylation is inseparable from the spatialized lactate concentration, which builds a bridge between epigenetics and metabolic reprogramming. Here, we review the important role of lactate in energy reprogramming, summarize the latest finding of lactylation in tumorigenesis and try to explore therapeutic strategies in oncotherapy that can kill two birds with one stone.

Indexed as

Lactic AcidNeoplasmsCarcinogenesisCell Transformation, NeoplasticEpigenesis, GeneticHistonesHumansTumor MicroenvironmentHistonesLactic Acid

Identifiers

PMID37060186
PMCPMC10542650
OpenAlexW4365810337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.